Home LiteratureArticle Details
PMID: 8546531 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).

Annals of the rheumatic diseases ·Vol. 54 ·No. 12 ·1995-12-00 ·Pages 983-7

Kuwana M, Okano Y, Kaburaki J, Inoko H

Abstract

To define further HLA class II gene associations with anticentromere antibody (ACA), a major serum antinuclear antibody in patients with systemic sclerosis (SSc). HLA class II genes were determined using polymerase chain reaction/restriction fragment length polymorphisms in 94 Japanese patients with SSc (22 ACA positive and 72 ACA negative) and 50 race matched normal control subjects. Frequency of DQB1*0501 was increased in ACA positive SSc patients compared with ACA negative SSc patients (36% versus 13%; p = 0.02, odds ratio = 4.0, 95% confidence interval 1.1 to 13.9), but the association of ACA with a polar amino acid at position 26 in the DQB1 beta 1 domain, which was demonstrated in white North Americans, was not observed in Japanese. The DRB1*0101, *0405, and *1302 alleles were associated with high ACA titres, whereas DRB1*1502 was associated with low ACA titres and a low frequency of centromere protein C (CENP-C) reactivity. These results suggest that the ACA response is associated with multiple HLA class II genes and that ACA positive SSc patients are heterogeneous in terms of immunogenetic background.

MeSH Terms
Alleles Autoantibodies/genetics Centromere/immunology Gene Frequency Genes, MHC Class II HLA-DQ Antigens HLA-DQ beta-Chains HLA-DR Antigens HLA-DRB1 Chains Humans Japan Polymerase Chain Reaction Polymorphism, Restriction Fragment Length Scleroderma, Systemic/genetics,immunology
Chemicals
Autoantibodies HLA-DQ Antigens HLA-DQ beta-Chains HLA-DQB1 antigen HLA-DR Antigens HLA-DRB1 Chains
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kuwana M
Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Okano Y
Kaburaki J
Inoko H
References (17)
17 references, click to expand
  1. Autoantibody to centromere (kinetochore) in scleroderma sera.
    Proc Natl Acad Sci U S A. 1980 Mar;77(3):1627-31 PMID: 6966403
  2. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.
    J Clin Invest. 1995 Jul;96(1):586-96 PMID: 7615831
  3. Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen.
    J Cell Biol. 1987 Apr;104(4):817-29 PMID: 2435739
  4. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.
    Arthritis Rheum. 1988 Feb;31(2):196-203 PMID: 3348823
  5. DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma.
    Tissue Antigens. 1989 Mar;33(3):418-20 PMID: 2568026
  6. Immunogenetic associations of scleroderma-related antinuclear antibodies.
    Arthritis Rheum. 1990 May;33(5):657-65 PMID: 2346521
  7. Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).
    J Clin Invest. 1992 Apr;89(4):1208-13 PMID: 1556182
  8. Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).
    J Clin Invest. 1992 Sep;90(3):973-80 PMID: 1326003
  9. A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis.
    Arthritis Rheum. 1993 Jul;36(7):943-54 PMID: 8318041
  10. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
    J Clin Invest. 1993 Sep;92(3):1296-301 PMID: 7690776
  11. Molecular genetics of systemic sclerosis.
    Curr Opin Rheumatol. 1993 Nov;5(6):753-9 PMID: 8117538
  12. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.
    Arthritis Rheum. 1994 Jan;37(1):75-83 PMID: 8129766
  13. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.
    Clin Exp Immunol. 1994 May;96(2):267-74 PMID: 8187334
  14. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.
    Arthritis Rheum. 1994 Jun;37(6):902-6 PMID: 8003063
  15. Major histocompatibility complex class II gene associations with anti-U1 small nuclear ribonucleoprotein antibody. Relationship to immunoreactivity with individual constituent proteins.
    Arthritis Rheum. 1995 Mar;38(3):396-405 PMID: 7533493
  16. HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies.
    Hum Immunol. 1995 Jan;42(1):35-42 PMID: 7751158
  17. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
    J Clin Invest. 1986 Feb;77(2):426-30 PMID: 3511098
Article Info
Journal
Annals of the rheumatic diseases
Abbr.
Ann Rheum Dis
ISSN
0003-4967
Published
1995-12-00
Pages
983-7
Language
English
Region
England
NLM ID
0372355
PMCID
PMC1010064
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com